Results

Total Results: 830 records

Showing results for "disorder".

441. Part 3: Trends in Access and Priorities of the National Quality Strategy—References | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part3-ref.html
     June 01, 2018 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

442. Federal Register Notice Seeks Public Input on AHRQ’s Framework for Patient-Centered Outcomes Research Investments | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/news/newsletters/e-newsletter/802.html
     February 01, 2022 - Disparities in United States hospitalizations for serious infections in patients with and without opioid use disorder

443. Nursing Home Resources | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/es/nursing-home/resources/search.html?page=1
     January 01, 2022 - Workers’ Stress In this video, Patricia Watson, PhD, of the National Center for Post Traumatic Stress Disorder

444. Nursing Home Resources | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/nursing-home/resources/search.html?page=1
     January 01, 2022 - Workers’ Stress In this video, Patricia Watson, PhD, of the National Center for Post Traumatic Stress Disorder

445. Tool 4: How To Deliver the Re-Engineered Discharge to Diverse Populations | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/red/toolkit/redtool4.html
     March 01, 2013 - Individuals who have been exposed to violence and trauma and are at heightened risk for posttraumatic stress disorder

446. CHIPRA 150 Section 6, Antipsychotics Testing Summary (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-metabolic-monitoring-testing-summary.pdf
     December 31, 2015 - CHIPRA 150 Section 6, Antipsychotics Testing Summary Measure Submission Summary Measure Name Metabolic Monitoring for Children and Adolescents on Antipsychotics Measure Number: 0150 NQF ID: NA Collection: NA Set…

447. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/policymakers/chipra/overview/background/appendix-b1.html
     December 01, 2009 - Substance Use ADHD Care CC-1 Follow-up care for children prescribed attention-deficit/hyperactivity disorder

448. Recommendations to Improve Children's Health Care Quality Measures | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/policymakers/chipra/pubs/background-2012/backgrndapb.html
     December 01, 2012 - Key: ADHD = attention deficit/hyperactivity disorder; AHRQ = Agency for Healthcare Research and Quality

449. Use of Multiple Concurrent Antipsychotics in Children (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
     May 01, 2018 - antipsychotic use among youth included male sex, public insurance, and a diagnosis of psychosis, tic disorder … , or pervasive development disorder or mental retardation (Olfson, et al., 2006).

450. PCMH FAQ and Contact Information | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/ncepcr/research/care-coordination/pcmh/faq.html
     August 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

451. Publications | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/priority-populations/publications/index.html
     June 01, 2021 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

452. 2. Synthesis of Key Findings by Category | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/final-report/section2.html
     October 01, 2015 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

453. Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/es/topics/index.html
     October 01, 2008 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

454. Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/topics/index.html
     October 01, 2008 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

455. Spotlight on Idaho -- The National Evaluation of the CHIPRA Quality Demonstration Grant Program (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/statesummaries/chipra-750-idaho-state-snapshot.pdf
     January 01, 2018 - , adolescent depression screening, and diagnosis and treatment of attention deficit hyperactivity disorder

456. Spotlight on South Carolina -- The National Evaluation of the CHIPRA Quality Demonstration Grant Program (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/statesummaries/chipra-750-south-carolina-state-snapshot.pdf
     January 01, 2018 - improved adherence to national guidelines for asthma, obesity, and attention deficit hyperactivity disorder

457. Spotlight on Oregon -- The National Evaluation of the CHIPRA Quality Demonstration Grant Program (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/statesummaries/chipra-750-oregon-state-snapshot.pdf
     January 01, 2018 - including developing care plans specifically for certain conditions such as asthma or attention deficit disorder

458. Challenges in Approaching Diagnostic Safety Unique to Children | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-pediatric-safety-2.html
     August 01, 2023 - Pediatric diagnoses such as Kawasaki disease, bronchiolitis, autism spectrum disorder, and juvenile idiopathic

459. Racial Disparities in Patient Safety Indicator (PSI) Rates in the Veterans Health Administration (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Shimada_65.pdf
     April 04, 2008 - Racial Disparities in Patient Safety Indicator (PSI) Rates in the Veterans Health Administration Racial Disparities in Patient Safety Indicator (PSI) Rates in the Veterans Health Administration Stephanie L. Shimada, PhD; Maria E. Montez-Rath, PhD; Susan A. Loveland, MAT; Shibei Zhao, MPH; Nancy R. Kressin, PhD; A…

460. At the American Society of Health Economists Conference, AHRQ to Highlight Its Deep Dive into COVID-19 | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/news/blog/ahrqviews/deep-dive-into-covid19.html
     June 01, 2023 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …